• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高密度脂蛋白 3 可刺激脂肪细胞释放纤溶酶原激活物抑制剂-1,但高密度脂蛋白 2 不可:这与鞘氨醇-1-磷酸有关。

HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate.

机构信息

Division of Endocrinology, Metabolism, and Medical Genetics, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.

出版信息

J Lipid Res. 2010 Sep;51(9):2619-28. doi: 10.1194/jlr.M003988. Epub 2010 Jun 3.

DOI:10.1194/jlr.M003988
PMID:20522601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2918445/
Abstract

Sphingosine-1-phosphate (S1P) is a bioactive lysophospholipid that regulates numerous key cardiovascular functions. High-density lipoproteins (HDLs) are the major plasma lipoprotein carriers of S1P. Fibrinolysis is a physiological process that allows fibrin clot dissolution, and decreased fibrinolytic capacity may result from increased circulating levels of plasminogen activator inhibitor-1 (PAI-1). We examined the effect of S1P associated with HDL subfractions on PAI-1 secretion from 3T3 adipocytes. S1P concentration in HDL3 averaged twice that in HDL2. Incubation of adipocytes with increasing concentrations of S1P in HDL3, but not HDL2, or with S1P complexed to albumin stimulated PAI-I secretion in a concentration-dependent manner. Quantitative RT-PCR revealed that S1P(1-3) are expressed in 3T3 adipocytes, with S1P(2) expressed in the greatest amount. Treatment of adipocytes with the S1P(1) and S1P(3) antagonist VPC23019 did not block PAI-1 secretion. Inhibiting S1P(2) with JTE-013 or reducing the expression of the gene coding for S1P(2) using silencing RNA (siRNA) technology blocked PAI-1 secretion, suggesting that the S1P(2) receptor mediates PAI-1 secretion from adipocytes exposed to HDL3 or S1P. Treatment with the phospholipase C (PLC) inhibitor U73122, the protein kinase C (PKC) inhibitor RO-318425, or the Rho-associated protein kinase (ROCK) inhibitor Y27632 all significantly inhibited HDL3- and S1P-mediated PAI-1 release, suggesting that HDL3- and/or S1P-stimulated PAI-1 secretion from 3T3 cells is mediated by activation of multiple, downstream signaling pathways of S1P(2).

摘要

鞘氨醇-1-磷酸(S1P)是一种生物活性溶血磷脂,可调节多种关键的心血管功能。高密度脂蛋白(HDL)是 S1P 的主要血浆脂蛋白载体。纤溶是一种允许纤维蛋白凝块溶解的生理过程,而纤溶能力的降低可能是由于循环中纤溶酶原激活物抑制剂-1(PAI-1)水平升高所致。我们研究了与 HDL 亚组分相关的 S1P 对 3T3 脂肪细胞中 PAI-1 分泌的影响。HDL3 中的 S1P 浓度平均是 HDL2 的两倍。用浓度逐渐增加的 S1P 孵育 HDL3 中的脂肪细胞,但不是 HDL2,或用与白蛋白结合的 S1P 孵育,均可浓度依赖性地刺激 PAI-I 分泌。定量 RT-PCR 显示,3T3 脂肪细胞中表达 S1P(1-3),其中 S1P(2)表达量最大。用 S1P(1)和 S1P(3)拮抗剂 VPC23019 处理脂肪细胞不能阻断 PAI-1 的分泌。用 S1P(1)和 S1P(3)拮抗剂 VPC23019 处理脂肪细胞不能阻断 PAI-1 的分泌。用 S1P(2)抑制剂 JTE-013 或用沉默 RNA(siRNA)技术降低编码 S1P(2)的基因的表达阻断 PAI-1 的分泌,表明 S1P(2)受体介导暴露于 HDL3 或 S1P 的脂肪细胞中 PAI-1 的分泌。用磷脂酶 C(PLC)抑制剂 U73122、蛋白激酶 C(PKC)抑制剂 RO-318425 或 Rho 相关蛋白激酶(ROCK)抑制剂 Y27632 处理均可显著抑制 HDL3 和 S1P 介导的 PAI-1 释放,表明 HDL3 和/或 S1P 刺激 3T3 细胞中 PAI-1 的分泌是通过 S1P(2)的多个下游信号通路的激活介导的。

相似文献

1
HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate.高密度脂蛋白 3 可刺激脂肪细胞释放纤溶酶原激活物抑制剂-1,但高密度脂蛋白 2 不可:这与鞘氨醇-1-磷酸有关。
J Lipid Res. 2010 Sep;51(9):2619-28. doi: 10.1194/jlr.M003988. Epub 2010 Jun 3.
2
Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes.肥胖个体血浆中鞘氨醇-1-磷酸水平升高及其在脂肪细胞中增加纤溶酶原激活物抑制剂-1表达的能力。
Coron Artery Dis. 2013 Dec;24(8):642-50. doi: 10.1097/MCA.0000000000000033.
3
Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression.载脂蛋白依赖性鞘氨醇-1-磷酸对纤溶酶原激活物抑制剂-1 表达的影响。
J Atheroscler Thromb. 2017 Sep 1;24(9):954-969. doi: 10.5551/jat.37663. Epub 2017 Mar 17.
4
Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.鞘氨醇-1-磷酸和白细胞介素-1分别调节胶质母细胞瘤细胞中纤溶酶原激活物抑制剂-1和尿激酶型纤溶酶原激活物受体的表达:对侵袭性的影响
Mol Cancer Res. 2008 Sep;6(9):1469-77. doi: 10.1158/1541-7786.MCR-08-0082.
5
Cytokine IL-6 secretion by trophoblasts regulated via sphingosine-1-phosphate receptor 2 involving Rho/Rho-kinase and Rac1 signaling pathways.滋养层细胞通过鞘氨醇 1-磷酸受体 2 调节细胞因子白细胞介素 6 的分泌,涉及 Rho/Rho-kinase 和 Rac1 信号通路。
Mol Hum Reprod. 2013 Aug;19(8):528-38. doi: 10.1093/molehr/gat023. Epub 2013 Mar 27.
6
Effects of Sphingosine-1-Phosphate on Cell Viability, Differentiation, and Gene Expression of Adipocytes.鞘氨醇-1-磷酸对脂肪细胞活力、分化和基因表达的影响。
Int J Mol Sci. 2020 Dec 5;21(23):9284. doi: 10.3390/ijms21239284.
7
Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways.1-磷酸鞘氨醇诱导的Flk-1反式激活通过S1P1/S1P3依赖性β-抑制蛋白/c-Src途径刺激小鼠胚胎干细胞增殖。
Stem Cell Res. 2014 Jan;12(1):69-85. doi: 10.1016/j.scr.2013.08.013. Epub 2013 Sep 7.
8
Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-γ that regulates neoangiogenesis.1-磷酸鞘氨醇是过氧化物酶体增殖物激活受体γ的一种配体,该受体可调节新生血管形成。
FASEB J. 2015 Sep;29(9):3638-53. doi: 10.1096/fj.14-261289. Epub 2015 May 18.
9
Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by sphingosine 1-phosphate in HepG2 liver cells.1-磷酸鞘氨醇对HepG2肝癌细胞中纤溶酶原激活物抑制剂-1表达的转录后调控
Biochim Biophys Acta. 2012 Nov-Dec;1819(11-12):1132-41. doi: 10.1016/j.bbagrm.2012.07.001. Epub 2012 Jul 20.
10
Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate.Toll样受体2信号传导的选择性减弱可能解释了1-磷酸鞘氨醇的抗动脉粥样硬化作用。
Cardiovasc Res. 2008 Aug 1;79(3):537-44. doi: 10.1093/cvr/cvn087. Epub 2008 Apr 14.

引用本文的文献

1
The compensatory enrichment of sphingosine-1-phosphate on HDL in FSGS enhances the protective function of glomerular endothelial cells compared to MCD.与微小病变肾病相比,局灶节段性肾小球硬化症中高密度脂蛋白上鞘氨醇-1-磷酸的代偿性富集增强了肾小球内皮细胞的保护功能。
Sci Rep. 2025 Jan 9;15(1):1530. doi: 10.1038/s41598-025-85865-8.
2
Tale of two systems: the intertwining duality of fibrinolysis and lipoprotein metabolism.两个系统的故事:纤溶与脂蛋白代谢的交织双重性。
J Thromb Haemost. 2023 Oct;21(10):2679-2696. doi: 10.1016/j.jtha.2023.08.004. Epub 2023 Aug 12.
3
Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity.有机因子在非糖尿病性肥胖代谢变化中的关键调节作用
Metabolites. 2023 Feb 14;13(2):270. doi: 10.3390/metabo13020270.
4
Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis.脂蛋白亚组分、止血潜能与冠状动脉粥样硬化的相关性。
Dis Markers. 2022 Aug 30;2022:2993309. doi: 10.1155/2022/2993309. eCollection 2022.
5
Deoxysphingolipids Upregulate MMP-1, Downregulate TIMP-1, and Induce Cytotoxicity in Human Schwann Cells.脱氧鞘氨醇脂质上调 MMP-1,下调 TIMP-1,并诱导人雪旺细胞细胞毒性。
Neuromolecular Med. 2022 Sep;24(3):352-362. doi: 10.1007/s12017-021-08698-4. Epub 2021 Dec 1.
6
Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus.鞘脂类物质与系统性红斑狼疮的诊断、预后和器官损伤。
Front Immunol. 2020 Sep 25;11:586737. doi: 10.3389/fimmu.2020.586737. eCollection 2020.
7
Impact of Phospholipid Transfer Protein in Lipid Metabolism and Cardiovascular Diseases.磷脂转移蛋白对脂代谢和心血管疾病的影响。
Adv Exp Med Biol. 2020;1276:1-13. doi: 10.1007/978-981-15-6082-8_1.
8
Glycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetes.1 型糖尿病患者糖基化神经酰胺与肾功能障碍进展的关系。
J Clin Lipidol. 2019 May-Jun;13(3):481-491.e1. doi: 10.1016/j.jacl.2019.03.005. Epub 2019 Apr 3.
9
Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects.纤溶酶原激活物抑制剂-1水平与肥胖非糖尿病受试者的脂蛋白亚组分相关。
Int J Endocrinol. 2018 May 30;2018:9596054. doi: 10.1155/2018/9596054. eCollection 2018.
10
Metabolic profiling of plasma from cardiac surgical patients concurrently administered with tranexamic acid: DI-SPME-LC-MS analysis.同时接受氨甲环酸治疗的心脏外科手术患者血浆的代谢谱分析:直接浸入式固相微萃取-液相色谱-质谱联用分析
J Pharm Anal. 2014 Feb;4(1):6-13. doi: 10.1016/j.jpha.2013.03.002. Epub 2013 Apr 11.

本文引用的文献

1
Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate.鞘氨醇-1-磷酸对细胞核中组蛋白乙酰化的调控
Science. 2009 Sep 4;325(5945):1254-7. doi: 10.1126/science.1176709.
2
Sphingolipids in inflammation: pathological implications and potential therapeutic targets.炎症中的鞘脂:病理意义及潜在治疗靶点
Br J Pharmacol. 2009 Oct;158(4):982-93. doi: 10.1111/j.1476-5381.2009.00281.x. Epub 2009 Jun 25.
3
Role of adipose tissue in haemostasis, coagulation and fibrinolysis.脂肪组织在止血、凝血和纤维蛋白溶解中的作用。
Obes Rev. 2009 Sep;10(5):554-63. doi: 10.1111/j.1467-789X.2009.00593.x. Epub 2009 May 12.
4
Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin.鞘氨醇-1-磷酸:一种生物活性脂质,可赋予高密度脂蛋白通过一氧化氮和前列环素介导的血管保护作用。
Thromb Haemost. 2009 Apr;101(4):665-73.
5
Export and functions of sphingosine-1-phosphate.鞘氨醇-1-磷酸的输出与功能。
Biochim Biophys Acta. 2009 Jul;1791(7):692-6. doi: 10.1016/j.bbalip.2009.02.011. Epub 2009 Mar 4.
6
Sphingosine 1-phosphate receptor signaling.鞘氨醇-1-磷酸受体信号传导
Annu Rev Biochem. 2009;78:743-68. doi: 10.1146/annurev.biochem.78.072407.103733.
7
Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.天然和重组高密度脂蛋白通过细胞外信号调节激酶1/2激活心室心肌细胞中的信号转导和转录激活因子3:1-磷酸鞘氨醇的作用
Cardiovasc Res. 2009 May 1;82(2):313-23. doi: 10.1093/cvr/cvp024. Epub 2009 Jan 16.
8
Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.鞘氨醇-1-磷酸和白细胞介素-1分别调节胶质母细胞瘤细胞中纤溶酶原激活物抑制剂-1和尿激酶型纤溶酶原激活物受体的表达:对侵袭性的影响
Mol Cancer Res. 2008 Sep;6(9):1469-77. doi: 10.1158/1541-7786.MCR-08-0082.
9
Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system.心血管系统中的1-磷酸鞘氨醇信号传导及生物学活性
Biochim Biophys Acta. 2008 Sep;1781(9):483-8. doi: 10.1016/j.bbalip.2008.04.003. Epub 2008 Apr 22.
10
TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.转化生长因子-β1诱导血管平滑肌细胞中纤溶酶原激活物抑制剂-1的表达需要pp60(c-src)/表皮生长因子受体(Y845)和Rho/ROCK信号传导。
J Mol Cell Cardiol. 2008 Mar;44(3):527-38. doi: 10.1016/j.yjmcc.2007.12.006. Epub 2008 Jan 3.